<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04199650</url>
  </required_header>
  <id_info>
    <org_study_id>ARDS Plateau Criteria</org_study_id>
    <nct_id>NCT04199650</nct_id>
  </id_info>
  <brief_title>Definition of ARDS in Qinghai Province: Verification of Berlin Definition Plateau Criteria</brief_title>
  <official_title>Definition of Acute Respiratory Distress Syndrome in Plateau of Qinghai in China: Verification of Berlin Definition Plateau Criteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Affiliated Hospital of Qinghai University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The severity stratification criteria for acute respiratory distress syndrome (ARDS) in
      Xi'ning Qinghai province (mean altitude: 2200m) were clarified according to the oxygenation
      index (PaO2/FiO2).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a single-center retrospective study. According to the Berlin diagnostic
      standard, ARDS patients admitted to the Department of severe Medicine, affiliated Hospital of
      Qinghai University from January 2018 to December 2018 were divided into three groups: mild
      (153mmHg &lt; PaO2/ FiO2 ≥ 230 mmHg), moderate (76mmHg &lt; PaO2/ FiO2 ≥ 153 mmHg) and severe
      (PaO2/ FiO2 ≥ 76 mmHg). The ICU mortality, 28-day mortality, non-ventilator time in ICU, ICU
      hospitalization time and non-I hospitalization were observed respectively. The difference of
      CU time and total hospitalization days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Mortality during treatment in ICU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>28-days mortality rate</measure>
    <time_frame>28 days after discharge</time_frame>
    <description>Mortality at 28 days of hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilator Free time</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Ventilator time not used in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator time</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Ventilator time in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Total length of stay in hospital</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">253</enrollment>
  <condition>ARDS</condition>
  <condition>High Altitude</condition>
  <arm_group>
    <arm_group_label>Mild ARDS</arm_group_label>
    <description>153mmHg&lt;PaO2/FiO2≤230mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate ARDS</arm_group_label>
    <description>76mmHg&lt;PaO2/FiO2≤153mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe ARDS</arm_group_label>
    <description>PaO2/FiO2≤76mmHg</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        From January 2018 to December 2018, patients admitted to the department of critical care,
        affiliated hospital of qinghai university were diagnosed with acute respiratory distress
        syndrome according to Berlin Definition.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age

          -  Meet the diagnostic criteria of ARDS

          -  Receive invasive mechanical ventilation

        Exclusion Criteria:

          -  Receive a large number of hormone shock therapy in a short period of time

          -  Death within a short period of time (&lt; 24 h) after mechanical ventilation

          -  No chest imaging data

          -  Data missing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liu Xiaoqin, Bachelor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliated Hospital of Qinghai University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gan Guifen, Bachelor</last_name>
    <phone>15897083336</phone>
    <email>xzhd1991@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pan Chun, Doctor</last_name>
    <phone>13814009925</phone>
    <email>panchun1982@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ChunPan</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guifen Gan, Bachelor</last_name>
      <phone>15897083336</phone>
      <email>xzhd1991@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiaoqin Liu, Bachelor</last_name>
      <phone>17809821708</phone>
      <email>liuxq0411@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2019</study_first_posted>
  <last_update_submitted>December 13, 2019</last_update_submitted>
  <last_update_submitted_qc>December 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Chun Pan</investigator_full_name>
    <investigator_title>Deputy chief physician</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

